&lt;p&gt;Success of &lt;sup&gt;125&lt;/sup&gt;I-Seed Treatment in Vulvar Squamous-Cell Carcinoma with Aplastic Anemia: A Case Report&lt;/p&gt;

Ni, Qingtao; Chi, Pan; Guo, Qing; Wang, Peng; Sun, Guibo; Xiao, Shujun; Dai, Shengbin

doi:10.2147/ott.s283006

Cited by 2 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The choice of I-125 seeds seems nonstandard but it was the most suitable for this patient, relecting the concept of “individualized therapy.” Implantation of I-125 seeds has long effective time but low dosage, and accurate treatment positioning compared with conventional external beam radiotherapy. 14 It offers more treatment options for solid tumor patients who lost the chance of surgical resection and fear chemo/radiotherapy, as an ideal brachytherapy and option. Implantation of I-125 seeds may be used again several times and has no limit of cumulative dose, comparing with external irradiation therapy.…”

Section: Discussionmentioning

confidence: 99%

“…9 It has been reported that I-125 seeds was safe and effective in a variety of different tumors, such as head and neck cancer, 10 parotid adenoid cystic carcinoma, 11 high-grade gliomas, 12 papillary thyroid carcinoma recurrence, 13 and even in vulvar squamous cell cancer. 14 In this article, we described a case with LUSC patient who was treated using I-125 seeds in our department in recent years.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma

Chi

Guo

et al. 2022

Dose-Response

Self Cite

View full text Add to dashboard Cite

Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients.

show abstract

Section: Discussionmentioning

confidence: 99%